Found: 30
Select item for more details and to access through your institution.
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.
- Published in:
- Translational Psychiatry, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41398-021-01541-1
- By:
- Publication type:
- Article
99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Glutamate, Dopamine, and Schizophrenia.
- Published in:
- Annals of the New York Academy of Sciences, 2003, v. 1003, n. 1, p. 138, doi. 10.1196/annals.1300.063
- By:
- Publication type:
- Article
Brain γ-aminobutyric acid (GABA) detection in vivo with the J-editing <sup>1</sup>H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability.
- Published in:
- NMR in Biomedicine, 2016, v. 29, n. 7, p. 932, doi. 10.1002/nbm.3539
- By:
- Publication type:
- Article
Striatal and extrastriatal dopamine release measured with PET and [<sup>18</sup>F] fallypride.
- Published in:
- Synapse, 2010, v. 64, n. 5, p. 350, doi. 10.1002/syn.20734
- By:
- Publication type:
- Article
In vivo vulnerability to competition by endogenous dopamine: Comparison of the D<sub>2</sub> receptor agonist radiotracer (-)-N-[<sup>11</sup>C]propyl-norapomorphine ([<sup>11</sup>C]NPA) with the D<sub>2</sub> receptor antagonist radiotracer [<sup>11</sup>C]-raclopride
- Published in:
- Synapse, 2004, v. 52, n. 3, p. 188, doi. 10.1002/syn.20013
- By:
- Publication type:
- Article
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans.
- Published in:
- Synapse, 2002, v. 43, n. 1, p. 19, doi. 10.1002/syn.10010
- By:
- Publication type:
- Article
Stability of [<sup>123</sup>I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans.
- Published in:
- Synapse, 1999, v. 31, n. 4, p. 302, doi. 10.1002/(SICI)1098-2396(19990315)31:4<302::AID-SYN9>3.0.CO;2-A
- By:
- Publication type:
- Article
[<sup>11</sup>C]NNC 112 selectivity for dopamine D<sub>1</sub> and serotonin 5-HT<sub>2A</sub> receptors: a PET study in healthy human subjects.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2007, v. 27, n. 10, p. 1733, doi. 10.1038/sj.jcbfm.9600468
- By:
- Publication type:
- Article
Comparative Evaluation in Nonhuman Primates of Five PET Radiotracers for Imaging the Serotonin Transporters: [<sup>11</sup>C]McN 5652, [<sup>11</sup>C]ADAM, [<sup>11</sup>C]DASB, [<sup>11</sup>C]DAPA, and [<sup>11</sup>C]AFM.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2002, v. 22, n. 11, p. 1377, doi. 10.1097/00004647-200211000-00011
- By:
- Publication type:
- Article
Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 12, p. 2475, doi. 10.1038/npp.2013.150
- By:
- Publication type:
- Article
Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 7, p. 1245, doi. 10.1038/npp.2013.23
- By:
- Publication type:
- Article
Investigation of Cortical Glutamate-Glutamine and γ-Aminobutyric Acid in Obsessive-Compulsive Disorder by Proton Magnetic Resonance Spectroscopy.
- Published in:
- Neuropsychopharmacology, 2012, v. 37, n. 12, p. 2684, doi. 10.1038/npp.2012.132
- By:
- Publication type:
- Article
Sustained Recreational Use of Ecstasy Is Associated with Altered Pre and Postsynaptic Markers of Serotonin Transmission in Neocortical Areas: A PET Study with [<sup>11</sup>C]DASB and [<sup>11</sup>C]MDL 100907.
- Published in:
- Neuropsychopharmacology, 2012, v. 37, n. 6, p. 1465, doi. 10.1038/npp.2011.332
- By:
- Publication type:
- Article
Dose–Occupancy Study of Striatal and Extrastriatal Dopamine D<sub>2</sub> Receptors by Aripiprazole in Schizophrenia with PET and [<sup>18</sup>F]Fallypride.
- Published in:
- Neuropsychopharmacology, 2008, v. 33, n. 13, p. 3111, doi. 10.1038/npp.2008.33
- By:
- Publication type:
- Article
Modulation of Amphetamine-Induced Dopamine Release by Group II Metabotropic Glutamate Receptor Agonist LY354740 in Non-Human Primates Studied with Positron Emission Tomography.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 5, p. 967, doi. 10.1038/sj.npp.1300902
- By:
- Publication type:
- Article
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [<sup>11</sup>C]WAY 100635.
- Published in:
- Psychopharmacology, 2006, v. 189, n. 2, p. 155, doi. 10.1007/s00213-006-0543-8
- By:
- Publication type:
- Article
Estimating the effect of endogenous dopamine on baseline [<sup>11</sup>C]-(+)-PHNO binding in the human brain.
- Published in:
- Synapse, 2016, v. 70, n. 11, p. 453, doi. 10.1002/syn.21920
- By:
- Publication type:
- Article
Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 8, p. e2013211, doi. 10.1001/jamanetworkopen.2020.13211
- By:
- Publication type:
- Article
Amphetamine-induced striatal dopamine release in schizotypal personality disorder.
- Published in:
- Psychopharmacology, 2020, v. 237, n. 9, p. 2649, doi. 10.1007/s00213-020-05561-5
- By:
- Publication type:
- Article
Biodistribution and radiation dosimetry of the glycine transporter-1 ligand 11C-GSK931145 determined from primate and human whole-body PET.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Detecting schizophrenia with 3D structural brain MRI using deep learning.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41359-z
- By:
- Publication type:
- Article
Detecting schizophrenia with 3D structural brain MRI using deep learning.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41359-z
- By:
- Publication type:
- Article
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Increased prefrontal cortical D1 receptors in drug naïve patients with schizophrenia: a PET study with [11C]NNC112.
- Published in:
- Journal of Psychopharmacology, 2012, v. 26, n. 6, p. 794, doi. 10.1177/0269881111409265
- By:
- Publication type:
- Article
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.
- Published in:
- Journal of Psychopharmacology, 2011, v. 25, n. 6, p. 734, doi. 10.1177/0269881110388329
- By:
- Publication type:
- Article
Quantitative Analysis of (--)-N-<sup>11</sup>C-Propyl-Norapomorphine In Vivo Binding in Nonhuman Primates.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 2, p. 338
- By:
- Publication type:
- Article
In Vivo Quantification of Brain Serotonin Transporters in Humans Using [<sup>11</sup>C]McN 5652.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 9, p. 1465
- By:
- Publication type:
- Article